Teva Pharmaceuticals Europe BV
II - In-house lobbyists and trade/business/professional associations
Companies & groups
PIET HEINKADE, 107
20 Square Vergote
Mr Bhattacharjee Dipankar
President and CEO, Teva Pharmaceuticals Europe BV
Mr Tyssier Erick
Head of Government Affairs Europe
Established in 1901, Teva is a global generic pharmaceuticals leader and one of the top 10 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide, of which more than 54,000 in the European Union.
Teva specializes in development, production and marketing of a wide range of generic and branded products, as well as active pharmaceutical ingredients (API).
Public Health, Industrial and IP Policies, Pricing and Reimbursement Policies, Pharmaceutical legislation, European external trade agenda, European semester, global health.
- stainability, Quality and Access to thcare systems
- ealth / mHealth
- industrial policy Initiatives
- corporate social responsibility
75%: 2 50%: 2 25%: 1
|First name||Surname||Start Date||End Date|
European Generic Medicines Association (EGA)
Friends of Europe
01/2014 - 12/2014
500,000 € - 599,999 €
No funding received from the EU institutions during the last closed financial year.
Brussels office is composed of 3 people. 2 spending 75% (one arrived in August, the other one in November 2014) of their time on policy and advocacy activities and 1 additional personal spending 50% of his time. Financial information includes project costs, trade organisation fees together with our office facilities and travel related costs.
By its registration the organisation has signed the Transparency Register Code of Conduct.
The organisation has also declared to be bound to the following other Code:
EGA Code of Conduct